The lytic effects of detergent sclerosants on erythrocytes, platelets, endothelial cells and microparticles are attenuated by albumin and other plasma components in vitro

被引:83
作者
Parsi, K. [1 ,2 ]
Exner, T. [1 ]
Connor, D. E. [1 ,2 ]
Herbert, A. [1 ,2 ]
Ma, D. D. F. [1 ,2 ]
Joseph, J. E. [1 ,2 ]
机构
[1] St Vincents Hosp, Haematol Res Lab, Sydney, NSW 2010, Australia
[2] Univ New S Wales, Sydney, NSW, Australia
关键词
sclerosants; haemolysis; platelets; endothelial cells; microparticles; albumin;
D O I
10.1016/j.ejvs.2008.03.001
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To investigate the lytic effects of sodium tetradecyl sulphate (STS) and polidocanol (POL) on erythrocytes, platelets, endothelial cells and platelet-derived microparticle (PDMP) formation in vitro and the potential protective effects of serum albumin and agents such as procaine. Materials and methods: The effects of sclerosants were studied in blood samples obtained from normal individuals. Absorbance densitometry was used to assess the lytic effects of sclerosants on blood cells and cultured human microvascular endothelial cells (HMEC) in plasma and in saline. PDMP were quantified by flow cytometry. Results: Haemolysis occurred in whole blood at sclerosant concentrations greater than 0.25% for STS and above 0.45% for POL. Similar concentrations of both agents caused platelet and endothelial cell lysis. Both sclerosants released PDMP at low concentrations but destroyed PDMP at higher concentrations. Albumin significantly reduced the lytic effect of both sclerosants on all cells but had a greater inhibitory effect on POL. Protamine at 0.01% had a neutralising effect on STS, whereas procaine and lignocaine showed no such activity. Conclusions: Sclerosants at therapeutic concentrations lyse blood cells and endothelial cells in vitro. This effect is strongly reduced by serum albumin possibly contributing towards the tow incidence of thromboembolic complications of sclerotherapy. (C) 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:216 / 223
页数:8
相关论文
共 23 条
  • [1] HMEC-1 - ESTABLISHMENT OF AN IMMORTALIZED HUMAN MICROVASCULAR ENDOTHELIAL-CELL LINE
    ADES, EW
    CANDAL, FJ
    SWERLICK, RA
    GEORGE, VG
    SUMMERS, S
    BOSSE, DC
    LAWLEY, TJ
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 99 (06) : 683 - 690
  • [2] Sclerotherapy of craniofacial venous malformations: Complications and results
    Berenguer, B
    Burrows, PE
    Zurakowski, D
    Mulliken, JB
    [J]. PLASTIC AND RECONSTRUCTIVE SURGERY, 1999, 104 (01) : 1 - 11
  • [3] THE AUSTRALIAN POLIDOCANOL (AETHOXYSKLEROL) STUDY - RESULTS AT 2 YEARS
    CONRAD, P
    MALOUF, GM
    STACEY, MC
    [J]. DERMATOLOGIC SURGERY, 1995, 21 (04) : 334 - 336
  • [4] DACIE JV, 1975, PRACTICAL HAEMATOLOG, P195
  • [5] FEGAN G, 2003, FEGANS COMPRESSION S, P56
  • [6] FEGAN WG, 1971, PRACTITIONER, V207, P797
  • [7] Stroke after varicose vein foam injection sclerotherapy
    Forlee, MV
    Grouden, M
    Moore, DJ
    Shanik, G
    [J]. JOURNAL OF VASCULAR SURGERY, 2006, 43 (01) : 162 - 164
  • [8] GOLDMAN MP, 2007, SCLEROTHERAPY TREATM, P165
  • [9] GOLDMAN MP, 1995, SCLEROTHERAPY TREATM, P64
  • [10] GOLDMAN MP, 1995, SCLEROTHERAPY TREATM, P315